Biomagnetics Diagnostics Corporation, a medical device and biotechnology company, designs, patents, and markets diagnostic equipment and immunoassays, and other biotechnologies. Its products include High Throughput Screening–Magnetic Testing Platform (HTS-MTP) to provide qualitative and quantitative results from a single test by detecting the target virus through measuring the magnetic field of micro-particles bonded to the virus in a fraction of the time; and Integrated Optical Biosensor System that is based on protein-receptor binding, which brings two or more optically tagged receptors into close proximity using planar optical waveguides, and triggers fluorescence changes identified by tiny on-board detectors. Biomagnetics Diagnostics Corporation has a licensing and collaborative research and development agreement with Las Alamos National Security LLC for Integrated Optical BioSensor. The company was founded in 1997 and is based in Orangevale, California.
U.S. Market Performance
7D7 Days: -1.2%
3M3 Months: 13.1%
1Y1 Year: 22.8%
YTDYear to Date: 7.3%
Over the last 7 days, the market has dropped 1.2%, driven by a loss of 4.7% in the Consumer Discretionary sector. In contrast to the last week, the market is actually up 23% over the past year. Earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.